Search

The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying innovative bioproducts from over a dozen member companies that are tackling the

Professor Vincent A. Fischetti is the inventor of phage lysins as a new therapeutic and an alternative to conventional antibiotics

Banco Sabadell stands as the firm’s main private institutional investor, like in its previous fund in 2018. Other Investors include the European Investment Fund and Alantra

For International Day of Women and Girls in Science, 14 women from 12 companies will host young female students to encourage them to go into science and innovation and show them the different

ApTOLL is the first TLR4 antagonist neuroprotectant to achieve positive efficacy endpoints in acute ischemic stroke trials, decreasing significantly mortality and long-term functional disability

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today

BCN HEALTH ha publicado el estudio 'Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care' en la revista 'Expert Review of Pharmacoeconomics & Outcomes